John A. Copland

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Figure 1 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

  2026-06-17

• Supplementary Figure 7 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

  2026-06-17

• Supplementary Figure 6 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

  2026-06-17

• Supplementary Figure 3 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

  2026-06-17

• Supplementary Figure 5 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

  2026-06-17

• Supplementary Figure 2 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

  2026-06-17

• Supplementary Figure 4 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

  2026-06-17

• Abstract 2942: Inhibition of stearoyl-CoA desaturase 1 (SCD1) by SSI-4 as a therapeutic strategy in non-small cell lung cancer.

  Cancer Research · 2026-04-03

• Abstract 7333: Disrupting tumor lipid homeostasis by MUFA depletion drives cell death in HCC

  Cancer Research · 2026-04-03

• Synergistic Anticancer Activity of Cannabinoids and Terpenes Against Triple-Negative Breast Cancer Resistance

  International Journal of Molecular Sciences · 2026-03-17

• Abstract B014: GPNMB:CD44 signaling drives tumor progression in translocation renal cell carcinoma

  Cancer Research · 2026-03-13

• Synthesis and Evaluation of ⁶⁴ Cu-Labeled Small-Size Antibody Fragments for Immuno-PET Imaging of Thyroid-Stimulating Hormone Receptor in Thyroid Cancer

  Molecular Pharmaceutics · 2026-03-11

• Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth

  Cancer Immunology Research · 2026-01-21

• Targeting CSF1R to overcome myeloid cell suppression in CART therapy

  Blood · 2025-11-03 · 1 citations

• TMET-18. Inhibition of stearoyl-CoA desaturase prevents immunosuppressive phenotypic switch of macrophages and reprograms lipid metabolism in melanoma brain metastases

  Neuro-Oncology · 2025-11-01

• Lower <i>SYNJ2BP</i> Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis

  Cancer Genomics & Proteomics · 2025-10-28

• Analysis of Peroxisomal ABCD3 Transporter as a Prognostic Factor in Clear Cell Renal Cell Carcinoma

  Cancer Genomics & Proteomics · 2025-08-29

• PET Imaging of Thyroid-Stimulating Hormone Receptor (TSHR) in Oncocytic Thyroid Carcinoma for Monitoring TSHR CAR T-Cell Therapy Response

  Bioconjugate Chemistry · 2025-07-15

• Preclinical ImmunoPET Imaging of Thyroid-Stimulating Hormone Receptor Expression in Thyroid Cancer using [⁶⁴Cu]Cu-NOTA-TSHR-Ab

  Molecular Pharmaceutics · 2025-05-22 · 1 citations

• Abstract 5658: Overcoming resistance in mCRPC: drug discovery using PDX models and high-throughput drug screening

  Cancer Research · 2025-04-21